Purpura, Lawrence, Heisler, Thomas, Palmer, Steven et al. · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026 · DOI
This study compared three groups of people dealing with long-term effects from COVID-19: those with long COVID and ME/CFS, those with long COVID without ME/CFS, and those with symptoms after COVID-19 vaccination. While all three groups shared common symptoms like fatigue, the ME/CFS group experienced more widespread symptoms across their body. Interestingly, people in the vaccination-related group had higher rates of unusual symptoms like nerve pain and rashes, and their blood tests showed different patterns of autoimmune markers—substances that suggest the immune system may be attacking the body's own tissues.
This study is important because it provides clinical evidence that ME/CFS and post-vaccination syndromes may involve similar autoimmune mechanisms, suggesting researchers should investigate shared underlying pathways. The identification of distinct biomarker patterns could help clinicians better characterize these conditions and potentially develop more targeted treatments. Understanding these differences and similarities may improve diagnostic accuracy and lead to more appropriate management strategies for ME/CFS patients.
This study does not prove that vaccination causes post-acute syndrome—it only describes symptom and biomarker patterns in patients who reported symptoms after vaccination. The cross-sectional design means researchers observed groups at one point in time, so cause-and-effect relationships cannot be established. Additionally, the small PACVS sample size (n=28) limits the generalizability of findings specific to that group, and the study cannot explain why some people develop these conditions while others recover normally.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Purpura, Lawrence, Heisler, Thomas, Palmer, Steven, Shah, Jayesh, Graham, Abigail, Seo, Ga Young, et al. (2026). Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciaf624
BibTeX
@article{mecfsatlas-purpura-2026-overlapping-clinical,
author = {Purpura, Lawrence and Heisler, Thomas and Palmer, Steven and Shah, Jayesh and Graham, Abigail and Seo, Ga Young and Sturiza, Antonia and Javier, Xiomara and Pinto, Giselle and Rosa, Amanda and Bosco, Joan and Reis, Karl and Sobieszczyk, Magdalena E and Yin, Michael T},
title = {Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.},
journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
year = {2026},
doi = {10.1093/cid/ciaf624},
note = {PubMed: 41510565},
url = {https://www.mecfsatlas.com/evidence/purpura-2026-overlapping-clinical},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-26. https://www.mecfsatlas.com/evidence/purpura-2026-overlapping-clinical
Contribute
Private, reviewed by a human. Not a public comment thread.